United States Biotechnology & Medical Research

Vera Therapeutics, Inc. (VERA)

Vera Therapeutics CEO Fordyce Marshall executed multiple planned sales totaling over $3.5 million recently. These transactions occurred following the company's August results financiers, which showed a 5% earnings beat. Despite these divestments, the stock price remains down 5.3% over the last quarter, trading near the lower end of its fifty-two-week range.
Ticker: VERA Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Vera Therapeutics, Inc.. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.0
Fordyce Marshall PRESIDENT AND CEO Executive Director
Transaction date
Planned sale
Price
442.66
Quantity 71,302 +10.3%
Value US$2,298,409
3.0
Fordyce Marshall PRESIDENT AND CEO Executive Director
Transaction date
Planned sale
Price
258.59
Quantity 56,413 +1.8%
Value US$2,353,056
3.0
MARSHALL FORDYCE Director; Officer Executive Director
Transaction date
Proposed sale
Price
180.24
Quantity 85,274
Value US$2,420,713
3.0
Fordyce Marshall PRESIDENT AND CEO Executive Director
Transaction date
Planned sale
Price
43.59
Quantity 2,200 -1.4%
Value US$95,908
3.0
Fordyce Marshall PRESIDENT AND CEO Executive Director
Transaction date
Planned sale
Price
42.86
Quantity 10,500 -6.4%
Value US$450,007
3.0
Fordyce Marshall PRESIDENT AND CEO Executive Director
Transaction date
Planned sale
Price
42.07
Quantity 32,550 -16.5%
Value US$1,369,496
3.0
Fordyce Marshall PRESIDENT AND CEO Executive Director
Transaction date
Planned sale
Price
40.78
Quantity 1,000 -0.5%
Value US$40,776
3.0
Fordyce Marshall PRESIDENT AND CEO Executive Director
Transaction date
Planned sale
Price
38.43
Quantity 88 -0.0%
Value US$3,382
3.0
Fordyce Marshall PRESIDENT AND CEO Executive Director
Transaction date
Planned sale
Price
37.93
Quantity 18,412 -8.5%
Value US$698,387
3.0
MARSHALL FORDYCE Director; Officer Executive Director
Transaction date
Proposed sale
Price
38.43
Quantity 74,000
Value US$2,843,820
3.0
Fordyce Marshall PRESIDENT AND CEO Executive Director
Transaction date
Planned sale
Price
37.09
Quantity 4,281 -1.9%
Value US$158,769
3.0
Fordyce Marshall PRESIDENT AND CEO Executive Director
Transaction date
Planned sale
Price
36.64
Quantity 14,219 -6.0%
Value US$520,978
3.0
MARSHALL FORDYCE Director; Officer Executive Director
Transaction date
Proposed sale
Price
36.61
Quantity 18,500
Value US$677,285
3.0
Fordyce Marshall PRESIDENT AND CEO Executive Director
Transaction date
Planned sale
Price
45.51
Quantity 900 -0.4%
Value US$40,960
3.0
Fordyce Marshall PRESIDENT AND CEO Executive Director
Transaction date
Planned sale
Price
44.58
Quantity 7,921 -3.2%
Value US$353,106
3.0
Fordyce Marshall PRESIDENT AND CEO Executive Director
Transaction date
Planned sale
Price
43.66
Quantity 14,130 -5.5%
Value US$616,985
3.0
MARSHALL FORDYCE Director; Officer Executive Director
Transaction date
Proposed sale
Price
43.71
Quantity 22,951
Value US$1,003,188
3.0
Brenner Robert Chief Medical Officer Officer
Transaction date
Sale
Price
41.98
Quantity 2,151 -4.1%
Value US$90,307
3.7
Young Joseph R SVP, FINANCE, CHIEF ACCT OFFCR Officer
Transaction date
Sale
Price
41.98
Quantity 3,117 -4.6%
Value US$130,864
3.0
Grant Sean CHIEF FINANCIAL OFFICER Officer
Transaction date
Sale
Price
41.98
Quantity 4,949 -4.2%
Value US$207,778
3.0
Fordyce Marshall PRESIDENT AND CEO Executive Director
Transaction date
Sale
Price
41.98
Quantity 16,925 -6.2%
Value US$710,578
3.0
JOHNSON DAVID LEE Chief Operating Officer Officer
Transaction date
Sale
Price
41.98
Quantity 2,579 -5.3%
Value US$108,276
3.0
Turner William D. Chief Regulatory Officer Officer
Transaction date
Sale
Price
41.98
Quantity 2,187 -4.6%
Value US$91,819
3.0
Skelton Laurence Matthew Chief Commercial Officer Officer
Transaction date
Sale
Price
41.98
Quantity 1,582 -2.4%
Value US$66,419
3.0
LAURENCE SKELTON Officer Officer
Transaction date
Proposed sale
Price
42.04
Quantity 1,800
Value US$75,663
3.0
WILLIAM DONALD TURNER Officer Officer
Transaction date
Proposed sale
Price
42.04
Quantity 2,600
Value US$109,291
3.0
SEAN GRANT Officer Officer
Transaction date
Proposed sale
Price
42.04
Quantity 5,700
Value US$239,600
3.0
ROBERT BRENNER Officer Officer
Transaction date
Proposed sale
Price
42.04
Quantity 2,500
Value US$105,088
3.0
DAVID L JOHNSON Officer Officer
Transaction date
Proposed sale
Price
42.04
Quantity 2,900
Value US$121,902
3.0
MARSHALL FORDYCE Officer Officer
Transaction date
Proposed sale
Price
42.04
Quantity 16,600
Value US$697,781
3.0
Turner William D. Chief Regulatory Officer Officer
Transaction date
Planned sale
Price
50.08
Quantity 10,000 -30.8%
Value US$500,767
3.0
WILLIAM TURNER Officer Officer
Transaction date
Proposed sale
Price
49.80
Quantity 10,000
Value US$498,000
3.6
ENRIGHT PATRICK G Non-Executive Director
Transaction date
Purchase
Price
42.50
Quantity 5,882 New position
Value US$249,985
3.0
Turner William D. Chief Regulatory Officer Officer
Transaction date
Planned sale
Price
45.31
Quantity 10,000 -30.8%
Value US$453,053
3.0
WILLIAM TURNER Officer Officer
Transaction date
Proposed sale
Price
44.90
Quantity 10,000
Value US$449,000
3.0
Turner William D. Chief Regulatory Officer Officer
Transaction date
Planned sale
Price
40.00
Quantity 10,000 -30.8%
Value US$400,000
0.5
Carter Jason S Chief Legal Officer Officer
Transaction date
Sale
Price
27.82
Quantity 3,864 -7.3%
Value US$107,498
0.5
Carter Jason S Officer Officer
Transaction date
Proposed sale
Price
27.87
Quantity 3,864
Value US$107,690
3.7
Young Joseph R SVP, FINANCE, CHIEF ACCT OFFCR Officer
Transaction date
Planned sale
Price
29.06
Quantity 15,000 -23.9%
Value US$435,874
3.6
ENRIGHT PATRICK G Non-Executive Director
Transaction date
Purchase
Price
22.35
Quantity 27,071 +0.8%
Value US$605,083
3.6
ENRIGHT PATRICK G Non-Executive Director
Transaction date
Purchase
Price
22.35
Quantity 13,536 +0.8%
Value US$302,553
3.6
ENRIGHT PATRICK G Non-Executive Director
Transaction date
Purchase
Price
20.87
Quantity 139,595 +4.1%
Value US$2,913,110
3.6
ENRIGHT PATRICK G Non-Executive Director
Transaction date
Purchase
Price
20.87
Quantity 69,798 +4.1%
Value US$1,456,566
3.0
Fordyce Marshall PRESIDENT AND CEO Executive Director
Transaction date
Planned sale
Price
28.32
Quantity 1,100 -0.5%
Value US$31,150
3.0
Fordyce Marshall PRESIDENT AND CEO Executive Director
Transaction date
Planned sale
Price
27.55
Quantity 7,975 -3.7%
Value US$219,732
3.0
MARSHALL FORDYCE Director; Officer Executive Director
Transaction date
Proposed sale
Price
27.10
Quantity 9,075
Value US$245,932
3.0
Fordyce Marshall PRESIDENT AND CEO Executive Director
Transaction date
Planned sale
Price
27.89
Quantity 10,613 -4.7%
Value US$296,032
3.0
Fordyce Marshall PRESIDENT AND CEO Executive Director
Transaction date
Planned sale
Price
42.00
Quantity 1,875 -1.3%
Value US$78,750
3.0
Fordyce Marshall PRESIDENT AND CEO Executive Director
Transaction date
Planned sale
Price
42.03
Quantity 5,650 -3.8%
Value US$237,489
3.0
Fordyce Marshall PRESIDENT AND CEO Executive Director
Transaction date
Planned sale
Price
41.53
Quantity 9,975 -6.5%
Value US$414,297
3.0
MARSHALL FORDYCE Director; Officer Executive Director
Transaction date
Proposed sale
Price
42.10
Quantity 17,500
Value US$736,750
3.0
Fordyce Marshall PRESIDENT AND CEO Executive Director
Transaction date
Planned sale
Price
43.81
Quantity 1,875 -2.1%
Value US$82,144
3.0
Fordyce Marshall PRESIDENT AND CEO Executive Director
Transaction date
Planned sale
Price
44.03
Quantity 4,635 -5.1%
Value US$204,094
3.0
Fordyce Marshall PRESIDENT AND CEO Executive Director
Transaction date
Planned sale
Price
43.52
Quantity 5,023 -5.5%
Value US$218,609
3.0
Fordyce Marshall PRESIDENT AND CEO Executive Director
Transaction date
Planned sale
Price
42.35
Quantity 2,195 -2.5%
Value US$92,949
3.0
Fordyce Marshall PRESIDENT AND CEO Executive Director
Transaction date
Planned sale
Price
41.33
Quantity 3,772 -4.2%
Value US$155,883
3.0
MARSHALL FORDYCE Director; Officer Executive Director
Transaction date
Proposed sale
Price
43.91
Quantity 17,500
Value US$768,425
3.0
Fordyce Marshall PRESIDENT AND CEO Executive Director
Transaction date
Planned sale
Price
47.65
Quantity 100 -0.1%
Value US$4,765
3.0
Fordyce Marshall PRESIDENT AND CEO Executive Director
Transaction date
Planned sale
Price
46.94
Quantity 1,775 -2.0%
Value US$83,325
3.0
Fordyce Marshall PRESIDENT AND CEO Executive Director
Transaction date
Planned sale
Price
47.55
Quantity 700 -0.8%
Value US$33,284
3.0
Fordyce Marshall PRESIDENT AND CEO Executive Director
Transaction date
Planned sale
Price
46.91
Quantity 14,925 -14.8%
Value US$700,150
3.0
MARSHALL FORDYCE Director; Officer Executive Director
Transaction date
Proposed sale
Price
46.92
Quantity 17,500
Value US$821,100
3.0
Fordyce Marshall PRESIDENT AND CEO Executive Director
Transaction date
Planned sale
Price
49.00
Quantity 1,875 -2.1%
Value US$91,875
3.0
Fordyce Marshall PRESIDENT AND CEO Executive Director
Transaction date
Planned sale
Price
48.76
Quantity 1,875 -2.1%
Value US$91,425
3.0
Fordyce Marshall PRESIDENT AND CEO Executive Director
Transaction date
Planned sale
Price
48.80
Quantity 1,381 -1.6%
Value US$67,399
3.0
Fordyce Marshall PRESIDENT AND CEO Executive Director
Transaction date
Planned sale
Price
48.18
Quantity 7,665 -8.2%
Value US$369,330
3.0
Fordyce Marshall PRESIDENT AND CEO Executive Director
Transaction date
Planned sale
Price
47.05
Quantity 6,579 -7.1%
Value US$309,532
3.0
MARSHALL FORDYCE Director; Officer Executive Director
Transaction date
Proposed sale
Price
48.31
Quantity 19,375
Value US$936,006
3.0
Fordyce Marshall PRESIDENT AND CEO Executive Director
Transaction date
Planned sale
Price
49.00
Quantity 7,500 -8.0%
Value US$367,500
3.0
Fordyce Marshall PRESIDENT AND CEO Executive Director
Transaction date
Planned sale
Price
49.50
Quantity 1,875 -2.1%
Value US$92,811
3.0
Fordyce Marshall PRESIDENT AND CEO Executive Director
Transaction date
Planned sale
Price
49.52
Quantity 1,875 -2.1%
Value US$92,848
3.0
Fordyce Marshall PRESIDENT AND CEO Executive Director
Transaction date
Planned sale
Price
49.57
Quantity 1,875 -2.1%
Value US$92,951
3.0
Fordyce Marshall PRESIDENT AND CEO Executive Director
Transaction date
Planned sale
Price
50.35
Quantity 310 -0.4%
Value US$15,609
3.0
Fordyce Marshall PRESIDENT AND CEO Executive Director
Transaction date
Planned sale
Price
49.59
Quantity 1,565 -1.8%
Value US$77,603
3.0
Fordyce Marshall PRESIDENT AND CEO Executive Director
Transaction date
Planned sale
Price
51.20
Quantity 100 -0.1%
Value US$5,120
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-17 2026-09-15 PlS Planned sale
3.0
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
71,302 +10.3%
442.66
US$2,298,409 		71,302 +10.3% 442.66 US$2,298,409
2026-09-04 2026-09-02 PlS Planned sale
3.0
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
56,413 +1.8%
258.59
US$2,353,056 		56,413 +1.8% 258.59 US$2,353,056
2026-09-02 2026-09-02 PrS Proposed sale
3.0
MARSHALL FORDYCE

Director; Officer

Executive Director
85,274
180.24
US$2,420,713 		85,274 180.24 US$2,420,713
2026-07-09 2026-07-07 PlS Planned sale
3.0
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
2,200 -1.4%
43.59
US$95,908 		2,200 -1.4% 43.59 US$95,908
2026-07-09 2026-07-07 PlS Planned sale
3.0
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
10,500 -6.4%
42.86
US$450,007 		10,500 -6.4% 42.86 US$450,007
2026-07-09 2026-07-07 PlS Planned sale
3.0
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
32,550 -16.5%
42.07
US$1,369,496 		32,550 -16.5% 42.07 US$1,369,496
2026-07-09 2026-07-07 PlS Planned sale
3.0
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
1,000 -0.5%
40.78
US$40,776 		1,000 -0.5% 40.78 US$40,776
2026-06-24 2026-06-23 PlS Planned sale
3.0
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
88 -0.0%
38.43
US$3,382 		88 -0.0% 38.43 US$3,382
2026-06-24 2026-06-23 PlS Planned sale
3.0
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
18,412 -8.5%
37.93
US$698,387 		18,412 -8.5% 37.93 US$698,387
2026-06-23 2026-06-23 PrS Proposed sale
3.0
MARSHALL FORDYCE

Director; Officer

Executive Director
74,000
38.43
US$2,843,820 		74,000 38.43 US$2,843,820
2026-05-13 2026-05-12 PlS Planned sale
3.0
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
4,281 -1.9%
37.09
US$158,769 		4,281 -1.9% 37.09 US$158,769
2026-05-13 2026-05-12 PlS Planned sale
3.0
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
14,219 -6.0%
36.64
US$520,978 		14,219 -6.0% 36.64 US$520,978
2026-05-12 2026-05-12 PrS Proposed sale
3.0
MARSHALL FORDYCE

Director; Officer

Executive Director
18,500
36.61
US$677,285 		18,500 36.61 US$677,285
2026-04-15 2026-04-14 PlS Planned sale
3.0
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
900 -0.4%
45.51
US$40,960 		900 -0.4% 45.51 US$40,960
2026-04-15 2026-04-14 PlS Planned sale
3.0
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
7,921 -3.2%
44.58
US$353,106 		7,921 -3.2% 44.58 US$353,106
2026-04-15 2026-04-14 PlS Planned sale
3.0
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
14,130 -5.5%
43.66
US$616,985 		14,130 -5.5% 43.66 US$616,985
2026-04-14 2026-04-14 PrS Proposed sale
3.0
MARSHALL FORDYCE

Director; Officer

Executive Director
22,951
43.71
US$1,003,188 		22,951 43.71 US$1,003,188
2026-02-25 2026-02-23 S Sale
3.0
Brenner Robert

Chief Medical Officer

Officer
2,151 -4.1%
41.98
US$90,307 		2,151 -4.1% 41.98 US$90,307
2026-02-25 2026-02-23 S Sale
3.7
Young Joseph R

SVP, FINANCE, CHIEF ACCT OFFCR

Officer
3,117 -4.6%
41.98
US$130,864 		3,117 -4.6% 41.98 US$130,864
2026-02-25 2026-02-23 S Sale
3.0
Grant Sean

CHIEF FINANCIAL OFFICER

Officer
4,949 -4.2%
41.98
US$207,778 		4,949 -4.2% 41.98 US$207,778
2026-02-25 2026-02-23 S Sale
3.0
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
16,925 -6.2%
41.98
US$710,578 		16,925 -6.2% 41.98 US$710,578
2026-02-25 2026-02-23 S Sale
3.0
JOHNSON DAVID LEE

Chief Operating Officer

Officer
2,579 -5.3%
41.98
US$108,276 		2,579 -5.3% 41.98 US$108,276
2026-02-25 2026-02-23 S Sale
3.0
Turner William D.

Chief Regulatory Officer

Officer
2,187 -4.6%
41.98
US$91,819 		2,187 -4.6% 41.98 US$91,819
2026-02-25 2026-02-23 S Sale
3.0
Skelton Laurence Matthew

Chief Commercial Officer

Officer
1,582 -2.4%
41.98
US$66,419 		1,582 -2.4% 41.98 US$66,419
2026-02-23 2026-02-23 PrS Proposed sale
3.0
LAURENCE SKELTON

Officer

Officer
1,800
42.04
US$75,663 		1,800 42.04 US$75,663
2026-02-23 2026-02-23 PrS Proposed sale
3.0
WILLIAM DONALD TURNER

Officer

Officer
2,600
42.04
US$109,291 		2,600 42.04 US$109,291
2026-02-23 2026-02-23 PrS Proposed sale
3.0
SEAN GRANT

Officer

Officer
5,700
42.04
US$239,600 		5,700 42.04 US$239,600
2026-02-23 2026-02-23 PrS Proposed sale
3.0
ROBERT BRENNER

Officer

Officer
2,500
42.04
US$105,088 		2,500 42.04 US$105,088
2026-02-23 2026-02-23 PrS Proposed sale
3.0
DAVID L JOHNSON

Officer

Officer
2,900
42.04
US$121,902 		2,900 42.04 US$121,902
2026-02-23 2026-02-23 PrS Proposed sale
3.0
MARSHALL FORDYCE

Officer

Officer
16,600
42.04
US$697,781 		16,600 42.04 US$697,781
2025-12-17 2025-12-15 PlS Planned sale
3.0
Turner William D.

Chief Regulatory Officer

Officer
10,000 -30.8%
50.08
US$500,767 		10,000 -30.8% 50.08 US$500,767
2025-12-15 2025-12-15 PrS Proposed sale
3.0
WILLIAM TURNER

Officer

Officer
10,000
49.80
US$498,000 		10,000 49.80 US$498,000
2025-12-15 2025-12-11 B Purchase
3.6
ENRIGHT PATRICK G
Non-Executive Director
5,882 New position
42.50
US$249,985 		5,882 New position 42.50 US$249,985
2025-12-10 2025-12-08 PlS Planned sale
3.0
Turner William D.

Chief Regulatory Officer

Officer
10,000 -30.8%
45.31
US$453,053 		10,000 -30.8% 45.31 US$453,053
2025-12-08 2025-12-08 PrS Proposed sale
3.0
WILLIAM TURNER

Officer

Officer
10,000
44.90
US$449,000 		10,000 44.90 US$449,000
2025-12-04 2025-12-03 PlS Planned sale
3.0
Turner William D.

Chief Regulatory Officer

Officer
10,000 -30.8%
40.00
US$400,000 		10,000 -30.8% 40.00 US$400,000
2025-11-25 2025-11-21 S Sale
0.5
Carter Jason S

Chief Legal Officer

Officer
3,864 -7.3%
27.82
US$107,498 		3,864 -7.3% 27.82 US$107,498
2025-11-24 2025-11-21 PrS Proposed sale
0.5
Carter Jason S

Officer

Officer
3,864
27.87
US$107,690 		3,864 27.87 US$107,690
2025-11-13 2025-11-11 PlS Planned sale
3.7
Young Joseph R

SVP, FINANCE, CHIEF ACCT OFFCR

Officer
15,000 -23.9%
29.06
US$435,874 		15,000 -23.9% 29.06 US$435,874
2025-06-25 2025-06-24 B Purchase
3.6
ENRIGHT PATRICK G
Non-Executive Director
27,071 +0.8%
22.35
US$605,083 		27,071 +0.8% 22.35 US$605,083
2025-06-25 2025-06-24 B Purchase
3.6
ENRIGHT PATRICK G
Non-Executive Director
13,536 +0.8%
22.35
US$302,553 		13,536 +0.8% 22.35 US$302,553
2025-06-25 2025-06-23 B Purchase
3.6
ENRIGHT PATRICK G
Non-Executive Director
139,595 +4.1%
20.87
US$2,913,110 		139,595 +4.1% 20.87 US$2,913,110
2025-06-25 2025-06-23 B Purchase
3.6
ENRIGHT PATRICK G
Non-Executive Director
69,798 +4.1%
20.87
US$1,456,566 		69,798 +4.1% 20.87 US$1,456,566
2025-02-27 2025-02-26 PlS Planned sale
3.0
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
1,100 -0.5%
28.32
US$31,150 		1,100 -0.5% 28.32 US$31,150
2025-02-27 2025-02-26 PlS Planned sale
3.0
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
7,975 -3.7%
27.55
US$219,732 		7,975 -3.7% 27.55 US$219,732
2025-02-26 2025-02-26 PrS Proposed sale
3.0
MARSHALL FORDYCE

Director; Officer

Executive Director
9,075
27.10
US$245,932 		9,075 27.10 US$245,932
2025-02-27 2025-02-21 PlS Planned sale
3.0
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
10,613 -4.7%
27.89
US$296,032 		10,613 -4.7% 27.89 US$296,032
2025-01-10 2025-01-08 PlS Planned sale
3.0
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
1,875 -1.3%
42.00
US$78,750 		1,875 -1.3% 42.00 US$78,750
2025-01-10 2025-01-08 PlS Planned sale
3.0
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
5,650 -3.8%
42.03
US$237,489 		5,650 -3.8% 42.03 US$237,489
2025-01-10 2025-01-08 PlS Planned sale
3.0
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
9,975 -6.5%
41.53
US$414,297 		9,975 -6.5% 41.53 US$414,297
2025-01-08 2025-01-08 PrS Proposed sale
3.0
MARSHALL FORDYCE

Director; Officer

Executive Director
17,500
42.10
US$736,750 		17,500 42.10 US$736,750
2024-12-20 2024-12-18 PlS Planned sale
3.0
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
1,875 -2.1%
43.81
US$82,144 		1,875 -2.1% 43.81 US$82,144
2024-12-20 2024-12-18 PlS Planned sale
3.0
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
4,635 -5.1%
44.03
US$204,094 		4,635 -5.1% 44.03 US$204,094
2024-12-20 2024-12-18 PlS Planned sale
3.0
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
5,023 -5.5%
43.52
US$218,609 		5,023 -5.5% 43.52 US$218,609
2024-12-20 2024-12-18 PlS Planned sale
3.0
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
2,195 -2.5%
42.35
US$92,949 		2,195 -2.5% 42.35 US$92,949
2024-12-20 2024-12-18 PlS Planned sale
3.0
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
3,772 -4.2%
41.33
US$155,883 		3,772 -4.2% 41.33 US$155,883
2024-12-18 2024-12-18 PrS Proposed sale
3.0
MARSHALL FORDYCE

Director; Officer

Executive Director
17,500
43.91
US$768,425 		17,500 43.91 US$768,425
2024-12-13 2024-12-11 PlS Planned sale
3.0
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
100 -0.1%
47.65
US$4,765 		100 -0.1% 47.65 US$4,765
2024-12-13 2024-12-11 PlS Planned sale
3.0
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
1,775 -2.0%
46.94
US$83,325 		1,775 -2.0% 46.94 US$83,325
2024-12-13 2024-12-11 PlS Planned sale
3.0
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
700 -0.8%
47.55
US$33,284 		700 -0.8% 47.55 US$33,284
2024-12-13 2024-12-11 PlS Planned sale
3.0
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
14,925 -14.8%
46.91
US$700,150 		14,925 -14.8% 46.91 US$700,150
2024-12-11 2024-12-11 PrS Proposed sale
3.0
MARSHALL FORDYCE

Director; Officer

Executive Director
17,500
46.92
US$821,100 		17,500 46.92 US$821,100
2024-11-27 2024-11-25 PlS Planned sale
3.0
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
1,875 -2.1%
49.00
US$91,875 		1,875 -2.1% 49.00 US$91,875
2024-11-27 2024-11-25 PlS Planned sale
3.0
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
1,875 -2.1%
48.76
US$91,425 		1,875 -2.1% 48.76 US$91,425
2024-11-27 2024-11-25 PlS Planned sale
3.0
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
1,381 -1.6%
48.80
US$67,399 		1,381 -1.6% 48.80 US$67,399
2024-11-27 2024-11-25 PlS Planned sale
3.0
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
7,665 -8.2%
48.18
US$369,330 		7,665 -8.2% 48.18 US$369,330
2024-11-27 2024-11-25 PlS Planned sale
3.0
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
6,579 -7.1%
47.05
US$309,532 		6,579 -7.1% 47.05 US$309,532
2024-11-25 2024-11-25 PrS Proposed sale
3.0
MARSHALL FORDYCE

Director; Officer

Executive Director
19,375
48.31
US$936,006 		19,375 48.31 US$936,006
2024-11-15 2024-11-13 PlS Planned sale
3.0
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
7,500 -8.0%
49.00
US$367,500 		7,500 -8.0% 49.00 US$367,500
2024-11-15 2024-11-13 PlS Planned sale
3.0
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
1,875 -2.1%
49.50
US$92,811 		1,875 -2.1% 49.50 US$92,811
2024-11-15 2024-11-13 PlS Planned sale
3.0
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
1,875 -2.1%
49.52
US$92,848 		1,875 -2.1% 49.52 US$92,848
2024-11-15 2024-11-13 PlS Planned sale
3.0
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
1,875 -2.1%
49.57
US$92,951 		1,875 -2.1% 49.57 US$92,951
2024-11-15 2024-11-13 PlS Planned sale
3.0
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
310 -0.4%
50.35
US$15,609 		310 -0.4% 50.35 US$15,609
2024-11-15 2024-11-13 PlS Planned sale
3.0
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
1,565 -1.8%
49.59
US$77,603 		1,565 -1.8% 49.59 US$77,603
2024-11-15 2024-11-13 PlS Planned sale
3.0
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
100 -0.1%
51.20
US$5,120 		100 -0.1% 51.20 US$5,120

See older Vera Therapeutics, Inc. insider trades

Plus unlocks the full transaction history.

See localized pricing at checkout
Unlock Vera Therapeutics, Inc. history with Plus

Billed monthly · Cancel anytime

Explore more

More insider trading research around Vera Therapeutics, Inc.

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America